January 08, 2026

A Turning Point in MASH

A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.

The Medicine Maker

January 06, 2026

Validation of Pathology-AI Integration Tool for Risk Stratification in Locally Advanced Colon Cancer Without Chemotherapy

The Combined Analysis of Pathology and Artificial Intelligence (AI; CAPAI) model effectively stratified patients with colon cancer into distinct prognostic groups, identifying nearly half as low-risk,...

The ASCO Post

January 05, 2026

Fistulizing Crohn's disease

Luca Stocchi, M.D., a colorectal surgeon at Mayo Clinic in Florida, presents a surgical case involving a 53-year-old male with long-standing, fistulizing Crohn's disease. The patient had a prior open ileocolic resection and subsequently developed progressive weight loss and anemia.

Mayo Clinic

January 02, 2026

Which First-Line Systemic Therapy Balances Survival and Quality of Life in Advanced Hepatocellular Carcinoma?

A network meta-analysis reported in JAMA Oncology found that among first-line systemic therapy options, immunotherapy-based combinations offered the most favorable therapeutic balance between survival...

The ASCO Post

January 02, 2026

Adding Dendritic Cell Vaccination to Hepatocellular Carcinoma Therapy

In patients with intermediate-stage hepatocellular carcinoma, can the addition of a vaccine of dendritic cells to transarterial chemoembolization (TACE) and preconditioning cyclophosphamide result in ...

The ASCO Post

December 18, 2025

FDA Approves Durvalumab With FLOT for Resectable Gastric/GEJ Adenocarcinoma

On November 25, 2025, the U.S. Food and Drug Administration (FDA) approved durvalumab (Imfinzi) in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy as neoadjuv...

The ASCO Post

December 09, 2025

Study Identifies Rectal Bleeding as Key Predictor of Early-Onset Colorectal Cancer

In individuals younger than age 50 undergoing a colonoscopy, greater odds for having colorectal cancer were observed among those who presented with rectal bleeding, according to findings from a study ...

The ASCO Post

December 05, 2025

Spectroscopy Uncovers Shared Oxidative Marker in Stored Fish Species

Autofluorescence analysis reveals a consistent FAD-linked signal across salmon, seabream, and amberjack during chilled storage

The Analytical Scientist

December 05, 2025

Final Overall Survival Confirms Benefit of Durvalumab Plus FLOT in Resectable Gastric and Gastroesophageal Junction Adenocarcinomas

The addition of the PD-L1–targeting monoclonal antibody durvalumab to conventional perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) resulted in a statistical...

The ASCO Post